Clinical trial
Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
NCT00350038 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00350038 |
|---|---|
| Title | Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions |
| Official title | Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry. |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Irbesartan, Ciprofibrate |
| Enrollment | 60 |
| Start date | Feb 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Jul 10, 2006 |
| Last update posted | Jan 23, 2008 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: